{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T07:10:03Z","timestamp":1793949003227,"version":"4.8.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s13346-022-01266-8","type":"journal-article","created":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T14:02:40Z","timestamp":1670421760000},"page":"1035-1047","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Cationic liposomes as promising vehicles for timolol\/brimonidine combination ocular delivery in glaucoma: formulation development and in vitro\/in vivo evaluation"],"prefix":"10.1007","volume":"13","author":[{"given":"Ali","family":"bigdeli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1441-3127","authenticated-orcid":false,"given":"Behzad Sharif","family":"Makhmalzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"Feghhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emad","family":"SoleimaniBiatiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,7]]},"reference":[{"key":"1266_CR1","doi-asserted-by":"crossref","unstructured":"Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma. JAMA.\u00a02014;311(18):1901\u20131911.","DOI":"10.1001\/jama.2014.3192"},{"key":"1266_CR2","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1136\/bjo.2005.081224","volume":"90","author":"HA Quigley","year":"2006","unstructured":"Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Omlthalmol. 2006;90:262\u20137.","journal-title":"Br J Omlthalmol"},{"key":"1266_CR3","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","volume":"121","author":"YC Tham","year":"2014","unstructured":"Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121:2081\u201390.","journal-title":"Ophthalmology"},{"issue":"5\u20136","key":"1266_CR4","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.drudis.2012.10.005","volume":"18","author":"L Gan","year":"2013","unstructured":"Gan L, Wang J, Jiang M, Bartlett H, Ouyang D, Eperjesi F, et al. Recent advance in topical ophthalmic drug delivery with lipid-based Nano carriers. Drug Discov Today. 2013;18(5\u20136):290\u20137.","journal-title":"Drug Discov Today"},{"key":"1266_CR5","doi-asserted-by":"crossref","unstructured":"Del Amo EM, Urtti A. Current and future ophthalmic drug delivery systems. A shift to the posterior segment. Drug Discov Today. 2008;13:135\u2013143.","DOI":"10.1016\/j.drudis.2007.11.002"},{"key":"1266_CR6","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jconrel.2018.05.020","volume":"281","author":"J Xu","year":"2018","unstructured":"Xu J, Xue Y, Hu G, Lin T, Gou J, Yin T, He H, Zhang Y, Tang X. A comprehensive review on contact lens for ophthalmic drug delivery. J Control Release. 2018;281:97\u2013118.","journal-title":"J Control Release"},{"issue":"3","key":"1266_CR7","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3928\/1542-8877-19950501-14","volume":"26","author":"SC Patel","year":"1995","unstructured":"Patel SC, Spaeth GL. Compliance in patients prescribed eyedrops for glaucoma. Ophthalmic Surg Lasers Imaging Retina. 1995;26(3):233\u20136.","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"1266_CR8","doi-asserted-by":"crossref","unstructured":"Kobelt-Nguyen G, Gerdtham UG, Alm A.\u00a0Costs of treating primary open-angle glaucoma and ocular hypertension: a retrospective, observational two-year chart review of newly diagnosed patients in Sweden and the United States.\u00a0J Glaucoma.\u00a01998;7(2):95\u2013104.","DOI":"10.1097\/00061198-199804000-00006"},{"issue":"2","key":"1266_CR9","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1097\/00061198-199201020-00012","volume":"1","author":"RN Weinreb","year":"1992","unstructured":"Weinreb RN. Compliance with medical treatment of glaucoma. J Glaucoma. 1992;1(2):134\u20136.","journal-title":"J Glaucoma"},{"key":"1266_CR10","doi-asserted-by":"crossref","unstructured":"Lichter PR, et al. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology.\u00a02001;108(11):1943\u201353.","DOI":"10.1016\/S0161-6420(01)00873-9"},{"key":"1266_CR11","doi-asserted-by":"crossref","unstructured":"Katz LJ. Modern alchemy: fixed combinations of glaucoma drugs.\u00a0Am j ophthalmol.\u00a02005;1(140):125\u201326.","DOI":"10.1016\/j.ajo.2005.03.034"},{"issue":"5","key":"1266_CR12","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.ophtha.2004.12.026","volume":"112","author":"AL Robin","year":"2005","unstructured":"Robin AL, Covert D. Does adjunctive glaucoma therapy affect adherence to the initial primary therapy? Ophthalmology. 2005;112(5):863\u20138.","journal-title":"Ophthalmology"},{"key":"1266_CR13","doi-asserted-by":"crossref","unstructured":"Holl\u00f3 G, et al. Long-term outcomes of prostaglandin analog versus timolol maleate in ocular hypertensive or primary open-angle glaucoma patients in Europe.\u00a0J Ocul Pharmacol Ther. 2011;27(5):493\u201398.","DOI":"10.1089\/jop.2011.0051"},{"issue":"2","key":"1266_CR14","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/00055735-200404000-00013","volume":"15","author":"RD Fechtner","year":"2004","unstructured":"Fechtner RD, Realini T. Fixed combinations of topical glaucoma medications. Curr Opin Ophthalmol. 2004;15(2):132\u20135.","journal-title":"Curr Opin Ophthalmol"},{"key":"1266_CR15","doi-asserted-by":"crossref","unstructured":"Samy KE, Cao Y, Kim J, Konichi da Silva NR, Phone A, Bloomer MM, Bhisitkul RB, Desai TA. Co-delivery of timolol and brimonidine with a polymer thin-film intraocular device. J Ocul Pharmacol Ther. 2019;35:124\u2013131.","DOI":"10.1089\/jop.2018.0096"},{"issue":"9","key":"1266_CR16","doi-asserted-by":"publisher","first-page":"753","DOI":"10.2165\/00002512-200623090-00005","volume":"23","author":"JE Frampton","year":"2006","unstructured":"Frampton JE. Topical brimonidine 0.2%\/timolol 0.5% ophthalmic solution. Drugs Aging. 2006;23(9):753\u201361.","journal-title":"Drugs Aging"},{"key":"1266_CR17","doi-asserted-by":"crossref","unstructured":"Goni FJ, Brimonidine\/Timolol Fixed Combination Study Group. 12-week study comparing the fixed combination of brimonidine and timolol with concomitant use of the individual components in patients with glaucoma and ocular hypertension.\u00a0Eur J Ophthalmol.\u00a02005;15(5):581\u201390.","DOI":"10.1177\/112067210501500508"},{"key":"1266_CR18","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1185\/030079907X178694","volume":"23","author":"ES Arcieri","year":"2007","unstructured":"Arcieri ES, Arcieri RS, Pereira ACA, Andreo EGV, Finotti IGA, S\u00e1Filho WF. Comparing the fixed combination brimonidine-timolol versus fixed combination dorzolamide-timolol in patients with elevated intraocular pressure. Curr Med Res Opin. 2007;23:683\u20139.","journal-title":"Curr Med Res Opin"},{"key":"1266_CR19","unstructured":"Schield's. Text book of glaucoma. 5th ed. Chapter 1 Cellular and molecular biology of aqueous humor dynamics. 15\u201317."},{"key":"1266_CR20","unstructured":"Katzung BG. Basic & clinical pharmacology. section II; chapter 6. Introduction to autonomic pharmacology. Pharmacology of Eye. 91."},{"key":"1266_CR21","unstructured":"Henderer\u00a0GD, Rapuano CJ. Goodman & Gilmans. Pharmacol Basis Ther. 1722-23."},{"key":"1266_CR22","doi-asserted-by":"crossref","unstructured":"Yellepeddi VK, Palakurthi S.\u00a0Recent advances in topical ocular drug delivery.\u00a0J Ocul Pharmacol Ther.\u00a02016;32(2):67-82.","DOI":"10.1089\/jop.2015.0047"},{"key":"1266_CR23","doi-asserted-by":"publisher","first-page":"495","DOI":"10.2147\/IJN.S30725","volume":"8","author":"M Honda","year":"2013","unstructured":"Honda M, Asai T, Oku N, Araki Y, Tanaka M, Ebihara N. Liposomes and nanotechnology in drug development: focus on ocular targets. Int J Nanomed. 2013;8:495.","journal-title":"Int J Nanomed"},{"key":"1266_CR24","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/S0022-2836(65)80093-6","volume":"13","author":"AD Bangham","year":"1965","unstructured":"Bangham AD, Standish MM, Watkins JC. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol. 1965;13:238\u201352.","journal-title":"J Mol Biol"},{"key":"1266_CR25","first-page":"3","volume":"5","author":"AA Elshanawane","year":"2014","unstructured":"Elshanawane AA, Abdolaziz LM, Mohram MS, Hafez HM. Development and validation of HPLC method for simultaneous estimation of Brimonidine tartrate and timolol maleate in bulk and pharmaceutical dosage forms. J Chromatograph SeparatTechniq. 2014;5:3.","journal-title":"J Chromatograph SeparatTechniq"},{"issue":"12","key":"1266_CR26","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1211\/0022357044896","volume":"56","author":"D Aggarwal","year":"2004","unstructured":"Aggarwal D, Garg A, Kaur IP. Development of a topical niosomal preparation of acetazolamide: preparation and evaluation. J Pharm Pharmacol. 2004;56(12):1509\u201317.","journal-title":"J Pharm Pharmacol"},{"issue":"2","key":"1266_CR27","first-page":"755","volume":"12","author":"S Maiti","year":"2011","unstructured":"Maiti S, Paul S, Mondol R, Ray S, Sa B. Nanovesicular formulation of brimonidine tartrate for the management of glaucoma: in vitro and in vivo evaluation. AapsPharmscitech. 2011;12(2):755\u201363.","journal-title":"AapsPharmscitech"},{"key":"1266_CR28","doi-asserted-by":"crossref","unstructured":"Higuchi T. Mechanism of sustained action medication. Theoretical analysis of rate release of solid drugs dispersed in solid matrices. J Pharm Sci. 1963;52:1145-49.","DOI":"10.1002\/jps.2600521210"},{"issue":"3","key":"1266_CR29","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1442-9071.1992.tb00944.x","volume":"20","author":"MD Zhu","year":"1992","unstructured":"Zhu MD, Cai FY. Development of experimental chronic intraocular hypertension in the rabbit. Aust N Z J Ophthalmol. 1992;20(3):225\u201334.","journal-title":"Aust N Z J Ophthalmol"},{"issue":"1","key":"1266_CR30","first-page":"205","volume":"15","author":"M Kouchak","year":"2016","unstructured":"Kouchak M, Bahmandar R, Bavarsad N, Farrahi F. Ocular DorzolamideNanoliposomes for Prolonged IOP Reduction: in-vitro and in-vivo Evaluation in Rabbits. Iranian J Pharm Res: IJPR. 2016;15(1):205.","journal-title":"Iranian j pharm res: IJPR"},{"issue":"7","key":"1266_CR31","doi-asserted-by":"publisher","first-page":"955","DOI":"10.3109\/10717544.2014.893381","volume":"92","author":"V Pokharkar","year":"2015","unstructured":"Pokharkar V, Patil V, Mandpe L. Engineering of polymer-surfactant nanoparticles of doxycycline hydrochloride for ocular drug delivery. Drug Deliv. 2015;92(7):955\u201368.","journal-title":"Drug Deliv"},{"issue":"1\u20132","key":"1266_CR32","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ijpharm.2007.04.028","volume":"344","author":"K Morand","year":"2007","unstructured":"Morand K, Bartoletti AC, Bochot A, Barratt G, Brandely ML, Chast F. Liposomal amphotericin B eye drops to treat fungal keratitis: physico-chemical and formulation stability. Int J Pharm. 2007;344(1\u20132):150\u20133.","journal-title":"Int J Pharm"},{"key":"1266_CR33","volume-title":"Ophthalmic preparations","author":"G Hecht","year":"2001","unstructured":"Hecht G. Ophthalmic preparations. 4th ed. New York: University of Sciences in Philadelphia.\u00a02001.","edition":"4"},{"issue":"2","key":"1266_CR34","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0378-5173(00)00359-8","volume":"199","author":"IP Kaur","year":"2000","unstructured":"Kaur IP, Singh M, Kanwar M. Formulation and evaluation of ophthalmic preparations of acetazolamide. Int J Pharm. 2000;199(2):119\u201327.","journal-title":"Int J Pharm"},{"key":"1266_CR35","unstructured":"USP29-NF24. Pharmaceutical dosage forms, ophthalmic preparation and uniformity of dosage units chapters. In: The United States Pharmacopeia 29th, The National Formulary 24th. Rockville, MD: United States Pharmacopeial Convention, Inc.\u00a02005."},{"issue":"1\u20132","key":"1266_CR36","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/0168-3659(93)90103-C","volume":"25","author":"PD Scholes","year":"1993","unstructured":"Scholes PD, Coombes AG, Illum L, Daviz SS, Vert M, Davies MC. The preparation of sub-200 nm poly (lactide-co-glycolide) microspheres for site-specific drug delivery. J Control Release. 1993;25(1\u20132):145\u201353.","journal-title":"J Control Release"},{"issue":"3","key":"1266_CR37","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1167\/tvst.4.3.12","volume":"4","author":"MM Ibrahim","year":"2015","unstructured":"Ibrahim MM, Abd-Elgawad AE, Soliman OA, Jablonski MM. Natural bioadhesive biodegradable nanoparticle-based topical ophthalmic formulations for management of glaucoma. Translational vision science & technology. 2015;4(3):12\u20139.","journal-title":"Translational vision science & technology"},{"issue":"2\u20133","key":"1266_CR38","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/0168-3659(95)00164-6","volume":"39","author":"JC Leroux","year":"1996","unstructured":"Leroux JC, All\u00e9mann E, De Jaeghere F, Doelker E, Gurny R. Biodegradable nanoparticles\u2014from sustained release formulations to improved site specific drug delivery. J Control Release. 1996;39(2\u20133):339\u201350.","journal-title":"J Control Release"},{"issue":"1\u20132","key":"1266_CR39","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ijpharm.2004.12.030","volume":"296","author":"M Garcia-Fuentes","year":"2005","unstructured":"Garcia-Fuentes M, Torres D, Alonso MJ. New surface-modified lipid nanoparticles as delivery vehicles for salmon calcitonin. Int J Pharm. 2005;296(1\u20132):122\u201332.","journal-title":"Int J Pharm"},{"issue":"1\u20132","key":"1266_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0378-5173(02)00438-6","volume":"248","author":"IP Kaur","year":"2002","unstructured":"Kaur IP, Smitha R, Aggarwal D, Kapil M. Acetazolamide: future perspective in topical glaucoma therapeutics. Int J Pharm. 2002;248(1\u20132):1\u20134.","journal-title":"Int J Pharm"},{"key":"1266_CR41","doi-asserted-by":"crossref","unstructured":"Aggarwal D, Garg A, Kaur IP. Development of a topical niosomal preparation of acetazolamide: preparation and evaluation. J Pharm Pharmacol. 2004;56(12):1509-17.","DOI":"10.1211\/0022357044896"},{"issue":"8","key":"1266_CR42","doi-asserted-by":"publisher","first-page":"5629","DOI":"10.1167\/iovs.12-9513","volume":"54","author":"K Kashiwagi","year":"2013","unstructured":"Kashiwagi K, Ito K, Haniuda H, Ohtsubo S, Takeoka S. Development of latanoprost-loaded biodegradable nanosheet as a new drug delivery system for glaucoma. Invest Ophthalmol Vis Sci. 2013;54(8):5629\u201337.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1266_CR43","doi-asserted-by":"crossref","unstructured":"Nafee NA, Ismail FA, Boraie NA, Mortada LM. Mucoadhesive delivery systems. I. Evaluation of mucoadhesive polymers for buccal tablet formulation. Drug Develop Ind Pharm. 2004;30(9):985\u201393.","DOI":"10.1081\/DDC-200037245"},{"issue":"3","key":"1266_CR44","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.ejpb.2008.09.028","volume":"71","author":"GP Andrews","year":"2009","unstructured":"Andrews GP, Laverty TP, Jones DS. Mucoadhesive polymeric platforms for controlled drug delivery. Eur J Pharm Biopharm. 2009;71(3):505\u201318.","journal-title":"Eur J Pharm Biopharm"},{"issue":"11","key":"1266_CR45","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1016\/j.addr.2005.07.001","volume":"57","author":"JD Smart","year":"2005","unstructured":"Smart JD. The basics and underlying mechanisms of mucoadhesion. Adv Drug Deliv Rev. 2005;57(11):1556\u201368.","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"1266_CR46","doi-asserted-by":"publisher","first-page":"356","DOI":"10.4103\/0975-1483.71623","volume":"2","author":"P Prabhu","year":"2010","unstructured":"Prabhu P, Kumar RN, Koland M, Harish NM, Vijayanarayan K, Dhondge G, et al. Preparation and evaluation of nano-vesicles of brimonidine tartrate as an ocular drug delivery system. J Young Pharm. 2010;2(4):356\u201361.","journal-title":"J Young Pharm"},{"key":"1266_CR47","doi-asserted-by":"crossref","unstructured":"Hui-Hui Z, Qiu-Hua L, Zhi-Jun Y, Wei-San P, Shu-Fang N. Novel ophthalmic timolol meleate liposomal-hydrogel and its improved local glaucomatous therapeutic effect in vivo. Drug Del. 2011;18(7):502\u201310.","DOI":"10.3109\/10717544.2011.595839"},{"issue":"1","key":"1266_CR48","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ijpharm.2009.06.020","volume":"379","author":"N Li","year":"2009","unstructured":"Li N, Zhuang C, Wang M, Sun X, Nie S, Pan W. Liposome coated with low molecular weight chitosan and its potential use in ocular drug delivery. Int J Pharm. 2009;379(1):131\u20138.","journal-title":"Int J Pharm"},{"key":"1266_CR49","doi-asserted-by":"crossref","unstructured":"Ishikawa M, Yoshitomi T, Zorumski CF, Izumi Y. Experimentally induced mammalian models of glaucoma. BioMed Res Int. 2015;2015.","DOI":"10.1155\/2015\/281214"},{"issue":"12","key":"1266_CR50","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.kjms.2014.09.004","volume":"30","author":"DW Lu","year":"2014","unstructured":"Lu DW, Chen YH, Chang CJ, Chiang CH, Yao HY. Nitric oxide levels in the aqueous humor vary in different ocular hypertension experimental models. Kaohsiung J Med Sci. 2014;30(12):593\u20138.","journal-title":"Kaohsiung J Med Sci"},{"key":"1266_CR51","unstructured":"Xu Y, Chen Z, Song J. A study of experimental carbomer glaucoma and other experimental glaucoma in rabbits. [Zhonghuayankezazhi] Chin J Ophthalmol. 2002;38(3):172\u20135."},{"key":"1266_CR52","doi-asserted-by":"crossref","unstructured":"Kim HG, Park JW, Park SW. Experimental chronic ocular hypertension by anterior chamber injection of 0.3% carbomer solution in the rat. Clin Exp Ophthalmol. 2013;41(4):404\u201312.","DOI":"10.1111\/j.1442-9071.2012.02883.x"},{"issue":"3","key":"1266_CR53","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.3892\/etm.2017.4728","volume":"14","author":"H Liu","year":"2017","unstructured":"Liu H, Ding C. Establishment of an experimental glaucoma animal model: a comparison of microbead injection with or without hydroxypropyl methylcellulose. Exp Ther Med. 2017;14(3):1953\u201360.","journal-title":"Exp Ther Med"},{"issue":"4","key":"1266_CR54","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s13346-014-0196-9","volume":"4","author":"TT Wong","year":"2014","unstructured":"Wong TT, Novack GD, Natarajan JV, Ho CL, Htoon HM, Venkatraman SS. Nanomedicine for glaucoma: sustained release latanoprost offers a new therapeutic option with substantial benefits over eyedrops. Drug Deliv Transl Res. 2014;4(4):303\u20139.","journal-title":"Drug Deliv Transl Res"},{"issue":"3","key":"1266_CR55","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.1755-3768.2008.01495.x","volume":"88","author":"T Loftsson","year":"2010","unstructured":"Loftsson T, Thorisdottir S, Fridriksdottir H, Stefansson E. Enalaprilat and enalapril maleate eyedrops lower intraocular pressure in rabbits. Acta Ophthalmol. 2010;88(3):337\u201341.","journal-title":"Acta Ophthalmol"},{"key":"1266_CR56","doi-asserted-by":"crossref","unstructured":"Mohsen AM, Salama A, Kassem AA. Development of acetazolamide loaded bilosomes for improved ocular delivery: preparation, characterization and in vivo evaluation. J Drug Del Sci Technol. 2020;59:101910","DOI":"10.1016\/j.jddst.2020.101910"},{"key":"1266_CR57","doi-asserted-by":"crossref","unstructured":"Manchanda S, Sahoo PK. Topical delivery of acetazolamide by encapsulating in mucoadhesive nanoparticles. Asian J Pharm Sci. 2017;12(6):550\u20137.","DOI":"10.1016\/j.ajps.2017.04.005"},{"issue":"4","key":"1266_CR58","doi-asserted-by":"publisher","first-page":"256","DOI":"10.7897\/2230-8407.06457","volume":"6","author":"A Dubey","year":"2015","unstructured":"Dubey A, Prabhu P, Beladiya K, Nair N, Ghate V. Development and investigation of timolol maleate and latanoprost combination liposomes for the treatment of glaucoma. Int Res J Pharm. 2015;6(4):256\u201364.","journal-title":"Int Res J Pharm"},{"issue":"3","key":"1266_CR59","doi-asserted-by":"publisher","first-page":"112","DOI":"10.4103\/2230-973X.138340","volume":"4","author":"A Dubey","year":"2014","unstructured":"Dubey A, Prabhu P. Formulation and evaluation of stimuli-sensitive hydrogels of timolol maleate and brimonidine tartrate for the treatment of glaucoma. Int J Pharm Investig. 2014;4(3):112.","journal-title":"Int j pharm investig"},{"issue":"6","key":"1266_CR60","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3390\/ph13060126","volume":"13","author":"E Taka","year":"2020","unstructured":"Taka E, Karavasili C, Bouropoulos N, Moschakis T, Andreadis DD, Zacharis CK, Fatouros DG. Ocular co-delivery of timolol and brimonidine from a self-assembling peptide hydrogel for the treatment of glaucoma: in vitro and ex vivo evaluation. Pharmaceuticals. 2020;13(6):126.","journal-title":"Pharmaceuticals"},{"issue":"1","key":"1266_CR61","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.jconrel.2012.06.017","volume":"162","author":"CC Peng","year":"2012","unstructured":"Peng CC, Burke MT, Carbia BE, Plummer C, Chauhan A. Extended drug delivery by contact lenses for glaucoma therapy. J Control Release. 2012;162(1):152\u20138.","journal-title":"J Control Release"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-022-01266-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-022-01266-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-022-01266-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T19:24:37Z","timestamp":1677785077000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-022-01266-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,7]]},"references-count":61,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["1266"],"URL":"https:\/\/doi.org\/10.1007\/s13346-022-01266-8","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,7]]},"assertion":[{"value":"19 November 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Ahvaz Jundishapur University of Medical Sciences (2020\/02\/04.\/ IR.AJUMS.ABHC.REC.1399.070.).\u201d","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All authors are happy with this publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}